Artificial Intelligence to Measure Fibrosis Change on Liver Biopsy in MAESTRO-NASH, a Phase 3 52-Week Serial Liver Biopsy Study in 966 Patients With NASH Treated With Resmetirom or Placebo
This Site Uses Cookies and Your Choice Matters to Us
HistoIndex intends to use cookies to improve the site and enhance your web browsing experience. HistoIndex values your privacy, and your trust is important to us. By accepting Cookies, you are choosing to consent to the use of our cookies and its related processing.
